Murae Organisor Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2025 ,inter alia, to consider and approve Pursuant to Regulation 29(1) ....
Awaiting price reaction for this filing.
Murae Organisor Ltd (formerly Earum Pharmaceuticals Ltd, BSE code 542724) has informed BSE that its Board of Directors will meet on Thursday, 22nd May 2025 at 2:00 PM at the company's registered office in Ahmedabad. The main purpose of the meeting is to consider and approve the Audited Financial Results of the company for the quarter and full year ended 31st March 2025, along with the Auditor's Report. The intimation has been issued under SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015 (Regulation 29(1)). The letter is signed by Director Nitinkumar Tomar (DIN: 10820263) and dated 14th May 2025.
This is a routine advance notice ahead of the company's full-year earnings announcement. Shareholders should watch the results declared on 22nd May for the actual numbers, as audited yearly performance can drive short-term stock price moves.